What happened
The analysis used NHANES data on 10,977 adults in the United States. EGCG consumers had PhenoAge acceleration −0.53 years (low intake) and −0.62 years (high intake) versus non-consumers, and lower all-cause mortality (HR 0.83 and 0.82) over 7.9 years of follow-up (1,276 deaths).
In the worm C. elegans, EGCG lengthened life by up to 10.73% through peroxisome biogenesis and fatty-acid beta-oxidation.
Why it matters
Tea is one of the most widely consumed drinks in the world, and a half-year difference in a biological-age clock is the kind of signal that makes headlines. But the human part is observational, and the median intake was very low (0.16 mg a day), with no clear dose-response between low and high intake.
What comes next
The worm result is not a human result. What is missing is any evidence that an EGCG pill gives the same thing — there is none. The story is about tea drinking, not about supplements.
Observational in humans — intake from two 24-hour dietary recalls, no causation; the worm effect is not a human effect; no evidence that an EGCG pill gives the same result. Median intake was very low (0.16 mg/day) and there was no clear dose-response between low and high intake.